Beta-lactamase inhibition: therapeutic implications in infectious diseases ; St. Philip, Barbados, 20 - 21 January 1989
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Chicago, Ill. u.a.
Univ. of Chicago Press
1991
|
Schriftenreihe: | Reviews of infectious diseases / Supplement
13,9 |
Schlagworte: | |
Beschreibung: | Literaturangaben |
Beschreibung: | S. 723 - 777 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV004464392 | ||
003 | DE-604 | ||
005 | 20220404 | ||
007 | t | ||
008 | 910828s1991 |||| 10||| eng d | ||
035 | |a (OCoLC)35511834 | ||
035 | |a (DE-599)BVBBV004464392 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-19 |a DE-12 |a DE-29 |a DE-20 |a DE-355 | ||
245 | 1 | 0 | |a Beta-lactamase inhibition |b therapeutic implications in infectious diseases ; St. Philip, Barbados, 20 - 21 January 1989 |c guest ed.: John L. Ho |
264 | 1 | |a Chicago, Ill. u.a. |b Univ. of Chicago Press |c 1991 | |
300 | |a S. 723 - 777 | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Reviews of infectious diseases / Supplement |v 13,9 | |
500 | |a Literaturangaben | ||
650 | 0 | 7 | |a Lactamase |g beta- |0 (DE-588)4275367-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Inhibition |0 (DE-588)4273127-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Infektionskrankheit |0 (DE-588)4026879-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Lactamantibiotikum |g beta- |0 (DE-588)4166365-2 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 20.01.1989-21.01.1989 |z Barbados |2 gnd-content | |
689 | 0 | 0 | |a Lactamantibiotikum |g beta- |0 (DE-588)4166365-2 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Lactamase |g beta- |0 (DE-588)4275367-3 |D s |
689 | 1 | 1 | |a Inhibition |0 (DE-588)4273127-6 |D s |
689 | 1 | 2 | |a Infektionskrankheit |0 (DE-588)4026879-2 |D s |
689 | 1 | 3 | |a Therapie |0 (DE-588)4059798-2 |D s |
689 | 1 | |5 DE-604 | |
700 | 1 | |a Ho, John L. |e Sonstige |4 oth | |
810 | 2 | |a Supplement |t Reviews of infectious diseases |v 13,9 |w (DE-604)BV001576460 |9 13,9 | |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-002767432 |
Datensatz im Suchindex
_version_ | 1805087624520531968 |
---|---|
adam_text | |
any_adam_object | |
building | Verbundindex |
bvnumber | BV004464392 |
ctrlnum | (OCoLC)35511834 (DE-599)BVBBV004464392 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV004464392</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20220404</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">910828s1991 |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)35511834</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV004464392</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Beta-lactamase inhibition</subfield><subfield code="b">therapeutic implications in infectious diseases ; St. Philip, Barbados, 20 - 21 January 1989</subfield><subfield code="c">guest ed.: John L. Ho</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chicago, Ill. u.a.</subfield><subfield code="b">Univ. of Chicago Press</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">S. 723 - 777</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Reviews of infectious diseases / Supplement</subfield><subfield code="v">13,9</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lactamase</subfield><subfield code="g">beta-</subfield><subfield code="0">(DE-588)4275367-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Inhibition</subfield><subfield code="0">(DE-588)4273127-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Infektionskrankheit</subfield><subfield code="0">(DE-588)4026879-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lactamantibiotikum</subfield><subfield code="g">beta-</subfield><subfield code="0">(DE-588)4166365-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">20.01.1989-21.01.1989</subfield><subfield code="z">Barbados</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Lactamantibiotikum</subfield><subfield code="g">beta-</subfield><subfield code="0">(DE-588)4166365-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Lactamase</subfield><subfield code="g">beta-</subfield><subfield code="0">(DE-588)4275367-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Inhibition</subfield><subfield code="0">(DE-588)4273127-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Infektionskrankheit</subfield><subfield code="0">(DE-588)4026879-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ho, John L.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplement</subfield><subfield code="t">Reviews of infectious diseases</subfield><subfield code="v">13,9</subfield><subfield code="w">(DE-604)BV001576460</subfield><subfield code="9">13,9</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-002767432</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 20.01.1989-21.01.1989 Barbados gnd-content |
genre_facet | Konferenzschrift 20.01.1989-21.01.1989 Barbados |
id | DE-604.BV004464392 |
illustrated | Not Illustrated |
indexdate | 2024-07-20T08:55:05Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-002767432 |
oclc_num | 35511834 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM DE-12 DE-29 DE-20 DE-355 DE-BY-UBR |
owner_facet | DE-19 DE-BY-UBM DE-12 DE-29 DE-20 DE-355 DE-BY-UBR |
physical | S. 723 - 777 |
publishDate | 1991 |
publishDateSearch | 1991 |
publishDateSort | 1991 |
publisher | Univ. of Chicago Press |
record_format | marc |
series2 | Reviews of infectious diseases / Supplement |
spelling | Beta-lactamase inhibition therapeutic implications in infectious diseases ; St. Philip, Barbados, 20 - 21 January 1989 guest ed.: John L. Ho Chicago, Ill. u.a. Univ. of Chicago Press 1991 S. 723 - 777 txt rdacontent n rdamedia nc rdacarrier Reviews of infectious diseases / Supplement 13,9 Literaturangaben Lactamase beta- (DE-588)4275367-3 gnd rswk-swf Inhibition (DE-588)4273127-6 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf Infektionskrankheit (DE-588)4026879-2 gnd rswk-swf Lactamantibiotikum beta- (DE-588)4166365-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 20.01.1989-21.01.1989 Barbados gnd-content Lactamantibiotikum beta- (DE-588)4166365-2 s DE-604 Lactamase beta- (DE-588)4275367-3 s Inhibition (DE-588)4273127-6 s Infektionskrankheit (DE-588)4026879-2 s Therapie (DE-588)4059798-2 s Ho, John L. Sonstige oth Supplement Reviews of infectious diseases 13,9 (DE-604)BV001576460 13,9 |
spellingShingle | Beta-lactamase inhibition therapeutic implications in infectious diseases ; St. Philip, Barbados, 20 - 21 January 1989 Lactamase beta- (DE-588)4275367-3 gnd Inhibition (DE-588)4273127-6 gnd Therapie (DE-588)4059798-2 gnd Infektionskrankheit (DE-588)4026879-2 gnd Lactamantibiotikum beta- (DE-588)4166365-2 gnd |
subject_GND | (DE-588)4275367-3 (DE-588)4273127-6 (DE-588)4059798-2 (DE-588)4026879-2 (DE-588)4166365-2 (DE-588)1071861417 |
title | Beta-lactamase inhibition therapeutic implications in infectious diseases ; St. Philip, Barbados, 20 - 21 January 1989 |
title_auth | Beta-lactamase inhibition therapeutic implications in infectious diseases ; St. Philip, Barbados, 20 - 21 January 1989 |
title_exact_search | Beta-lactamase inhibition therapeutic implications in infectious diseases ; St. Philip, Barbados, 20 - 21 January 1989 |
title_full | Beta-lactamase inhibition therapeutic implications in infectious diseases ; St. Philip, Barbados, 20 - 21 January 1989 guest ed.: John L. Ho |
title_fullStr | Beta-lactamase inhibition therapeutic implications in infectious diseases ; St. Philip, Barbados, 20 - 21 January 1989 guest ed.: John L. Ho |
title_full_unstemmed | Beta-lactamase inhibition therapeutic implications in infectious diseases ; St. Philip, Barbados, 20 - 21 January 1989 guest ed.: John L. Ho |
title_short | Beta-lactamase inhibition |
title_sort | beta lactamase inhibition therapeutic implications in infectious diseases st philip barbados 20 21 january 1989 |
title_sub | therapeutic implications in infectious diseases ; St. Philip, Barbados, 20 - 21 January 1989 |
topic | Lactamase beta- (DE-588)4275367-3 gnd Inhibition (DE-588)4273127-6 gnd Therapie (DE-588)4059798-2 gnd Infektionskrankheit (DE-588)4026879-2 gnd Lactamantibiotikum beta- (DE-588)4166365-2 gnd |
topic_facet | Lactamase beta- Inhibition Therapie Infektionskrankheit Lactamantibiotikum beta- Konferenzschrift 20.01.1989-21.01.1989 Barbados |
volume_link | (DE-604)BV001576460 |
work_keys_str_mv | AT hojohnl betalactamaseinhibitiontherapeuticimplicationsininfectiousdiseasesstphilipbarbados2021january1989 |